VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
+9.33%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$19.6B
AUM Growth
+$1.29B
(+7.1%)
Cap. Flow
+$52.7M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
29.33%
Holding
681
New
30
Increased
359
Reduced
247
Closed
34
Top Buys
| 1 |
Franco-Nevada
FNV
|
$368M |
| 2 |
Zoetis
ZTS
|
$218M |
| 3 |
ATW
Atwood Oceanics
ATW
|
$125M |
| 4 |
Alamos Gold
AGI
|
$117M |
| 5 |
Marathon Petroleum
MPC
|
$115M |
Top Sells
| 1 |
KUB
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
|
$255M |
| 2 |
ESV
Ensco Rowan plc
ESV
|
$99M |
| 3 |
Archer Daniels Midland
ADM
|
$98.8M |
| 4 |
SFD
SMITHFIELD FOODS,INC
SFD
|
$79.6M |
| 5 |
Schlumberger
SLB
|
$78.6M |
Sector Composition
| 1 | Materials | 44.98% |
| 2 | Energy | 26.85% |
| 3 | Industrials | 4.45% |
| 4 | Healthcare | 4.41% |
| 5 | Consumer Staples | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDW
151
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
| $13.4M | 0.07% |
13,988,123
+925,930
| +7% | +$884K |
|
|
ARMH
152
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $13.2M | 0.07% |
273,974
-46,909
| -15% | -$2.26M |
|
153
Applied Materials
AMAT
$126B
| $12.8M | 0.07% |
732,589
-14,400
| -2% | -$252K |
|
154
Bristol-Myers Squibb
BMY
$95B
| $12.8M | 0.07% |
277,278
+18,833
| +7% | +$872K |
|
155
Merck
MRK
$210B
| $12.7M | 0.06% |
279,730
-63,671
| -19% | -$2.89M |
|
156
Micron Technology
MU
$139B
| $12.4M | 0.06% |
707,720
-114,686
| -14% | -$2M |
|
157
Sanofi
SNY
$111B
| $12.3M | 0.06% |
243,751
-6,252
| -3% | -$317K |
|
|
JOY
158
DELISTED
Joy Global Inc
JOY
| $11.9M | 0.06% |
233,896
-949
| -0.4% | -$48.4K |
|
159
AbbVie
ABBV
$376B
| $11.9M | 0.06% |
266,853
+13,587
| +5% | +$608K |
|
|
QGENF
160
DELISTED
QIAGEN NV
QGENF
| $11.9M | 0.06% |
555,659
+4,680
| +0.8% | +$100K |
|
161
GSK
GSK
$79.8B
| $11.7M | 0.06% |
187,020
-15,884
| -8% | -$996K |
|
162
AGNC Investment
AGNC
$10.6B
| $11.6M | 0.06% |
514,004
-57,791
| -10% | -$1.3M |
|
163
Bausch Health
BHC
$2.67B
| $11.2M | 0.06% |
107,676
-4,026
| -4% | -$420K |
|
164
AstraZeneca
AZN
$254B
| $11.1M | 0.06% |
427,462
+2,502
| +0.6% | +$65K |
|
165
Analog Devices
ADI
$121B
| $11M | 0.06% |
233,967
-9,559
| -4% | -$450K |
|
166
Novo Nordisk
NVO
$249B
| $11M | 0.06% |
648,220
+2,480
| +0.4% | +$42K |
|
|
SGEN
167
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.9M | 0.06% |
248,464
+12,009
| +5% | +$526K |
|
|
BTU
168
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $10.9M | 0.06% |
42,044
-389
| -0.9% | -$101K |
|
|
CRR
169
DELISTED
Carbo Ceramics Inc.
CRR
| $10.7M | 0.05% |
108,106
-26,080
| -19% | -$2.58M |
|
|
MDVN
170
DELISTED
MEDIVATION, INC.
MDVN
| $10.7M | 0.05% |
356,680
+14,364
| +4% | +$431K |
|
171
Teva Pharmaceuticals
TEVA
$21.2B
| $10.6M | 0.05% |
280,404
+3,224
| +1% | +$122K |
|
172
Abbott
ABT
$231B
| $10.3M | 0.05% |
310,664
+13,402
| +5% | +$445K |
|
173
Eli Lilly
LLY
$666B
| $10.3M | 0.05% |
204,461
-4,736
| -2% | -$238K |
|
174
Ionis Pharmaceuticals
IONS
$9.46B
| $10.3M | 0.05% |
+273,413
| New | +$10.3M |
|
|
BRD
175
DELISTED
BRIGUS GOLD CORP COM STK
BRD
| $10.3M | 0.05% |
17,089,922
+1,268,240
| +8% | +$761K |
|